Aigen Investment Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,534
Closed -$459K 928
2025
Q2
$459K Buy
+3,534
New +$512K 0.06% 420
2025
Q1
Sell
-2,645
Closed -$490K 880
2024
Q4
$490K Sell
2,645
-432
-14% -$83.9K 0.09% 338
2024
Q3
$649K Buy
+3,077
New +$535K 0.13% 236
2024
Q1
Sell
-3,122
Closed -$635K 845
2023
Q4
$635K Sell
3,122
-11,071
-78% -$1.79M 0.11% 260
2023
Q3
$2.82M Buy
14,193
+13,073
+1,167% +$3.3M 0.53% 12
2023
Q2
$364K Sell
1,120
-1,589
-59% -$454K 0.05% 428
2023
Q1
$634K Buy
2,709
+1,753
+183% +$443K 0.09% 271
2022
Q4
$241K Buy
+956
New +$204K 0.03% 411
2021
Q2
Sell
-3,688
Closed -$763K 596
2021
Q1
$763K Buy
3,688
+229
+7% +$48.7K 0.1% 216
2020
Q4
$651K Sell
3,459
-7,296
-68% -$1.19M 0.08% 306
2020
Q3
$1.39M Sell
10,755
-3,772
-26% -$416K 0.18% 179
2020
Q2
$1.26M Buy
14,527
+11,752
+423% +$903K 0.16% 191
2020
Q1
$167K Sell
2,775
-1,483
-35% -$110K 0.02% 754
2019
Q4
$316K Buy
+4,258
New +$274K 0.05% 426

Other funds holding INSP

Aigen Investment Management's INSP Position: Q3 2025 in Review

Aigen Investment Management sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 3,534 shares — an estimated $459K sold.

Aigen Investment Management first reported a position in INSP in Q4 2019 and held it in 14 quarters. The position peaked at $2.82M in Q3 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Aigen Investment Management reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Aigen Investment Management sold 3,534 Inspire Medical Systems shares in Q3 2025, an estimated $459K.
  • Aigen Investment Management first reported a position in Inspire Medical Systems in Q4 2019 and held it in 14 quarters.
  • Aigen Investment Management's Inspire Medical Systems position peaked at $2.82M in Q3 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Aigen Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.